Serum Institute of India

The Serum Institute of India (SII) was granted market authorisation by DCGI to manufacture Cervavac. This is India’s qHPV vaccine against cervical cancer.

As India gears up to begin a mega vaccination drive with two approved candidates - Bharat Biotech’s Covaxin and Pune-based Serum Institute’s Covishield, there are several pressing questions in citizens’ minds.

Currently in the spotlight for a possible COVID-19 vaccine, the company has been producing low-cost doses since 1966.

Phase-1 and Phase-2 trials by Oxford showed no adverse side-effects and generated an immune response among health participants.

For his extraordinary work in manufacturing and distributing vaccinations, Cyrus Poonawalla is known as one of the 'seven vaccine heroes of the world.'

A fast-acting anti-rabies drug, the first of its kind in the world, will be launched in India this year. The drug, named Rabishield, will instantly deactivate the rabies virus in cases of critical dog bites, thus protecting the patient.